Medline Inc.
34.05USD
-0.6400 (-1.84%)
Revenue
| (USD) | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| FY | 23.2B | 25.5B | 28.4B | 31.2B | 33.7B |
| Q1 | — | — | 6.6B | 7.4B | — |
| Q2 | — | — | 6.9B | 7.7B | — |
| Q3 | — | — | — | 7.7B | — |
| Q4 | — | — | — | 8.5B | — |
Revenue
| (USD) | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| FY | — | — | -.010 | 1.56 | 1.59 |
| Q1 | — | — | — | .160 | — |
| Q2 | — | — | — | .070 | — |
| Q3 | — | — | — | .347 | — |
| Q4 | — | — | — | .404 | — |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.